Search Results 721-730 of 18467 for prednisone
NOTE: Patients on low dose prednisone (=< 10 mg) for treatment of conditions other than CLL are eligible. Patients who have received more than 1 prior ...
Received prednisone doses >15mg/day or changes in immunosuppressive medications < 12 weeks prior to Screening (Visit 1); Recent (within 1 year) history of ...
Chronic oral prednisone or prednisolone therapy for at least 6 continuous months directly preceding Visit 1, and on a stable dose for at least one month prior ...
Prednisone; Raltegravir; Repaglinide; Rofecoxib; Sertraline; Triazolam; Trimetrexate; Valproic Acid; Zaleplon. Other Interactions. Certain medicines should not ...
... prednisone; Moderate to severe hip or knee arthritis; Self-reported medical conditions that could affect the skeletal system such as diabetes or other ...
Patients on ACTH, prednisone or other systemically (non-inhaled) administered steroids should be off the product greater than 28 days prior to screening.
Inhaled or topical steroids and adrenal replacement doses =< 10 mg/day prednisone equivalents are permitted in the absence of active autoimmune disease.
Patients receiving corticosteroids >10 mg/day prednisone (or other steroid equivalent) for any indication within 7 days before the onset of acute GVHD ...
... prednisone; enzalutamide; immunotherapy; cabazitaxel or mitoxantrone chemotherapy or radium-223. Diagnosis of metastatic kidney cancer based on standard of ...
NOTE: Inhaled steroids, low-dose corticosteroids (e.g., equivalent to or less than oral prednisone 10 mg daily), and steroid use for primary prevention of ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!